Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × tisagenlecleucel × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Completed 5 Active not recruiting 4 Withdrawn 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 147 Docetaxel 135 Carboplatin 133 Bevacizumab 133 pembrolizumab 128 Radiotherapy 122 Gemcitabine 122 Cisplatin 121 Paclitaxel 116 Capecitabine 107 Rituximab 102 Fluorouracil 97 Oxaliplatin 91 Nivolumab 80 Irinotecan 79 Leucovorin 77 Doxorubicin 75 Dexamethasone 71 Pemetrexed 68 fludarabine 65 fludarabine phosphate 62 Etoposide 62 Bortezomib 59 Erlotinib Hydrochloride 58 Cetuximab 54 Methotrexate 53 Cytarabine 52 Trastuzumab 49 Prednisone 45 Lenalidomide 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04161118 2023-05-06

TIGER-CTL019

University of Cologne

Phase 2 Terminated

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡